Bevacizumab induced hypertension in gynecologic cancer: Does it resolve after completion of therapy?()

Hypertension (HTN) induced by bevacizumab is a side effect that is often thought to resolve after treatment. However, there are currently no reports on rates of resolution. We assess the incidence and timing of the resolution of bevacizumab induced HTN. We evaluated all patients treated with bevaciz...

Descripción completa

Detalles Bibliográficos
Autores principales: Corr, Bradley R., Breed, Christopher, Sheeder, Jeanelle, Weisdack, Sarah, Behbakht, Kian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004251/
https://www.ncbi.nlm.nih.gov/pubmed/27617286
http://dx.doi.org/10.1016/j.gore.2016.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004251/
https://www.ncbi.nlm.nih.gov/pubmed/27617286
http://dx.doi.org/10.1016/j.gore.2016.06.002

Ejemplares similares